123 related articles for article (PubMed ID: 12637885)
1. [Value of MRI in symptomatic patients treated with tamoxifen].
Taïeb S; Ceugnart L; Chevalier A; Cabaret V; Leblanc E; Fournier C; Besson P
J Radiol; 2003 Jan; 84(1):33-9. PubMed ID: 12637885
[TBL] [Abstract][Full Text] [Related]
2. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
3. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation.
Ascher SM; Johnson JC; Barnes WA; Bae CJ; Patt RH; Zeman RK
Radiology; 1996 Jul; 200(1):105-10. PubMed ID: 8657895
[TBL] [Abstract][Full Text] [Related]
4. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
Hricak H; Finck S; Honda G; Göranson H
AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
[TBL] [Abstract][Full Text] [Related]
5. MRI evaluation of myometrial invasion by endometrial carcinoma. Comparison between fast-spin-echo T2w and coronal-FMPSPGR Gadolinium-Dota-enhanced sequences.
Nasi F; Fiocchi F; Pecchi A; Rivasi F; Torricelli P
Radiol Med; 2005 Sep; 110(3):199-210. PubMed ID: 16200042
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.
Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H
J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477
[TBL] [Abstract][Full Text] [Related]
7. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
8. Abnormal uterine cavity: differential diagnosis with MR imaging.
Imaoka I; Sugimura K; Masui T; Takehara Y; Ichijo K; Naito M
Magn Reson Imaging; 1999 Dec; 17(10):1445-55. PubMed ID: 10609993
[TBL] [Abstract][Full Text] [Related]
9. Benign and malignant diseases of the endometrium.
Chaudhry S; Reinhold C; Guermazi A; Khalili I; Maheshwari S
Top Magn Reson Imaging; 2003 Aug; 14(4):339-57. PubMed ID: 14578778
[No Abstract] [Full Text] [Related]
10. Endometrial polyps: MR imaging features.
Hase S; Mitsumori A; Inai R; Takemoto M; Matsubara S; Akamatsu N; Fujisawa M; Joja I; Sato S; Kanazawa S
Acta Med Okayama; 2012; 66(6):475-85. PubMed ID: 23254582
[TBL] [Abstract][Full Text] [Related]
11. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
[TBL] [Abstract][Full Text] [Related]
12. Comparison of endometrial pathologies collected by hysteroscopy and hysterectomy in postmenopausal breast cancer tamoxifen-treated patients.
Cohen I; Azaria R; Bernheim J; Tepper R; Sharony R; Beyth Y
Eur J Gynaecol Oncol; 2000; 21(4):418-22. PubMed ID: 11055500
[TBL] [Abstract][Full Text] [Related]
13. Endometrial cancer in polyps associated with tamoxifen use.
Ramondetta LM; Sherwood JB; Dunton CJ; Palazzo JP
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):340-1. PubMed ID: 9988797
[TBL] [Abstract][Full Text] [Related]
14. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
Hann LE; Gretz EM; Bach AM; Francis SM
AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding.
Fotiou S; Tserkezoglou A; Hadjieleftheriou G; Apostolikas N; Karydas I; Stravolemos K
Anticancer Res; 1998; 18(1B):625-9. PubMed ID: 9584044
[TBL] [Abstract][Full Text] [Related]
16. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging.
Yamashita Y; Mizutani H; Torashima M; Takahashi M; Miyazaki K; Okamura H; Ushijima H; Ohtake H; Tokunaga T
AJR Am J Roentgenol; 1993 Sep; 161(3):595-9. PubMed ID: 8352114
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-induced uterine abnormalities: the role of imaging.
Ascher SM; Imaoka I; Lage JM
Radiology; 2000 Jan; 214(1):29-38. PubMed ID: 10644098
[TBL] [Abstract][Full Text] [Related]
18. Does tamoxifen induce endometrial hyperplasia, carcinoma and polyps?
van den Bosch T; Vandendael A
S Afr Med J; 1994 Jun; 84(6):367-8. PubMed ID: 7740401
[No Abstract] [Full Text] [Related]
19. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen and endometrial pathologies: a prospective study.
Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H
Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
